Prostate-specific antigen (PSA) blood testing likely reduces the risk of death from prostate cancer, found a new review

Health-evidence reviewers reverse recommendation on a blood test that detects a biomarker of a common cancer after decades of controversy.

Prostate-specific antigen (PSA) blood testing likely reduces the risk of death from prostate cancer, found a new review

A major review of nearly 800,000 men has found prostate cancer screening using a specific test is likely to reduce deaths from the disease, but experts shared a warning